Dual-Targeting CAR-NK Cells for Recurrent/Progressive Glioblastoma and High-Grade Glioma

NCT07551336 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Glioma
High-Grade Gliomas
Glioblastoma
Recurrent High-Grade Gliomas
Recurrent Glioblastoma

Interventions

BIOLOGICAL: Dual-target CAR-NK cells
DRUG: Cyclophosphamide
DEVICE: Intracranial catheter/reservoir for locoregional delivery
DRUG: Fludarabine

Sponsor

Beijing Biotech